I-PORTIndividual Soldier's Portal (into the Synthetic Battlefield)
References in periodicals archive ?
The "i-PORT" system was originally developed by Kai Nissan Auto Sales Co., Ltd., a Nissan dealer headquartered in Kofu City, Yamanashi Prefecture, and one of its vendors.
The i-Port, introduced on a trial basis in May this year, has been used by 13 of Nissan's 142 dealers.
"As exclusive distributor of Medtronic's iPro2 Professional CGM system, along with the i-Port Advance, Henry Schein is pleased to offer our primary care physician customers a complete set of solutions to better care for their patients with type 2 diabetes."
i-port Advance provides a safe, effective, and easy way for people with diabetes to administer insulin, especially those on injection therapy who have needle-related bruising and scarring, pain and discomfort, or who experience anxiety from injecting their diabetes medications.
"Adding i-port Advance to our diabetes solutions portfolio puts us in a stronger position to support a broader group of people with diabetes - including those currently on injection therapy - with tools to help simplify diabetes management routines," said Jeff Hubauer, vice president and general manager of insulin delivery for the Diabetes business of Medtronic.
i-port is a small, circular, low profile device, about the size of a quarter, that stays on the skin like a bandage.
Each i-port Advance can be used for three days, during which time the person with diabetes injects their insulin into the port instead of directly into the skin.
With only one skin puncture every three days (when applying a new device) instead of multiple punctures each day, i-port Advance reduces bruising, pain and scar tissue while promoting healing.
Each i-port Advance comes with a disposable serter (insertion aid) that provides nearly pain-free application of i-port to the skin.
i-port Advance may be used on a wide range of patients, including adults and children.